Scotia calls in administrators:
This article was originally published in Clinica
Executive Summary
The Scotia group of companies, UK developers of Foscan, a photodynamic therapy for head and neck cancers, has gone into administration. The administrator, accountancy firm Ernst & Young, is not writing off Scotia completely, however. Joint administrator Andrew Wollaston said: "Scotia has developed an impressive intellectual property portfolio with both current and future value opportunities and our immediate strategy is to explore all options in order to preserve and enhance the company's key platform technologies, including Foscan."
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.